CNS Pharmaceuticals reports Q1 results

1 month ago 3

Earnings News

CNS Pharmaceuticals press release (NASDAQ:CNSP): Q1 net loss was approximately $4.3 million compared to approximately $3.5 million for the comparable period in 2024. The change in net loss is largely attributable to the costs of data clean-up, preparation and analysis for the topline

Recommended For You

More Trending News

Read Entire Article